Patents by Inventor Bo Chi

Bo Chi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrole amide compound and use thereof
    Patent number: 12527763
    Abstract: A pyrrole amide compound, a pharmaceutical composition thereof and use thereof. The compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: January 20, 2026
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jiancheng Wang, Xiaojun Wang, Yinglin Zuo, Yingxun Zhang, Yingjun Zhang, Bo Chi, Wei Han, Xiaohong Ding, Junnan Zeng
  • 3CLPRO PROTEASE INHIBITOR
    Publication number: 20250042889
    Abstract: Provided are a 3Clpro protease inhibitor, a pharmaceutical composition containing the compound of formula (I), and a method for treating coronavirus by using the compound.
    Type: Application
    Filed: September 6, 2022
    Publication date: February 6, 2025
    Applicants: SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD., QILU ANIMAL HEALTH PRODUCTS CO., LTD.
    Inventors: Junfei WANG, Cang CHENG, Bo CHI, Daqing SUN
  • PYRROLE AMIDE COMPOUND AND USE THEREOF
    Publication number: 20220211665
    Abstract: A pyrrole amide compound, a pharmaceutical composition thereof and use thereof. The compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.
    Type: Application
    Filed: October 21, 2020
    Publication date: July 7, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jiancheng WANG, Xiaojun WANG, Yinglin ZUO, Yingxun ZHANG, Yingjun ZHANG, Bo CHI, Wei HAN, Xiaohong DING, Junnan ZENG
  • PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUND AND USE THEREOF
    Publication number: 20210206760
    Abstract: A phenyl-substituted dihydronaphthyridine compound and use thereof, and further relates to a pharmaceutical composition including the compound. According to the present invention, the compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.
    Type: Application
    Filed: May 20, 2019
    Publication date: July 8, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Chuanwen YANG, Xiaojun WANG, Yinglin ZUO, Yingjun ZHANG, Jiancheng WANG, Hui WANG, Bo CHI
  • E-polylysine hydrogel and preparation method and application thereof
    Patent number: 9833539
    Abstract: The present invention discloses a ?-polylysine hydrogel and the preparation method and application of the as-described ?-polylysine hydrogel. The polylysine hydrogel is non-toxic to a recipient, and has biodegradability and biocompatibility. The wound tissue healing material prepared by the present invention can be used in wound tissue adhesion in an efficient, stable, safe manner.
    Type: Grant
    Filed: December 28, 2013
    Date of Patent: December 5, 2017
    Assignee: NANJING TECH UNIVERSITY
    Inventors: Hong Xu, Bo Chi, Rui Wang, Xiaohai Feng, Sha Li, Jinfeng Liang, Pingkai Ouyang
  • HYDROGEL BASED ON ?-POLYGLUTAMIC ACID AND ?-POLYLYSINE CROSSLINKED POLYMER, AND PREPARATION METHOD THEREFOR
    Publication number: 20170014543
    Abstract: A hydrogel based on a cross-linked ?-polyglutamic acid and ?-polylysine polymer is obtained by cross-linking of ?-polyglutamic acid with ?-polylysine, and it is a polymer having the following constitutional unit, wherein, m is a natural number of 15 to 45, n is a natural number of 3900 to 17000, and x is a natural number of 5 to 40. It also discloses a preparation method of as-described hydrogel and its application in preparation as a medical wound dressing.
    Type: Application
    Filed: December 28, 2013
    Publication date: January 19, 2017
    Applicant: NANJING TECH UNIVERSITY
    Inventors: Hong Xu, Bo Chi, Jun Xia, Sha Li, Xiaohai Feng
  • E-POLYLYSINE HYDROGEL AND PREPARATION METHOD AND APPLICATION THEREOF
    Publication number: 20170000924
    Abstract: The present invention discloses a ?-polylysine hydrogel and the preparation method and application of the as-described ?-polylysine hydrogel. The polylysine hydrogel is non-toxic to a recipient, and has biodegradability and biocompatibility. The wound tissue healing material prepared by the present invention can be used in wound tissue adhesion in an efficient, stable, safe manner.
    Type: Application
    Filed: December 28, 2013
    Publication date: January 5, 2017
    Applicant: NANJING TECH UNIVERSITY
    Inventors: Hong Xu, Bo Chi, Rui Wang, Xiaohai Feng, Sha Li, Jinfeng Liang, Pingkai Ouyang